Skip to content

Ultrasound-guided Continuous Adductor Canal Block for Analgesia After Total Knee Replacement: Comparison of Short-axis and Long-axis Techniques

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02799797
Enrollment
62
Registered
2016-06-15
Start date
2016-07-31
Completion date
2018-04-18
Last updated
2019-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia, Nerve Block, Total Knee Arthroplasty

Keywords

adductor canal block

Brief summary

This study compares the long-axis and short-axis technique of continues adductor canal block for total knee replacement surgery. Half participants will receive long-axis catheterization, while the other half will receive short-axis catheterization.

Interventions

PROCEDUREultrasound guided long axis placement of adductor canal catheter

The long axis of the ultrasound probe is placed parallel to the long axis of the adductor canal while scanning, and the catheter is placed along the long axis of the canal using an in-plane approach

PROCEDUREultrasound guided short axis placement of adductor canal catheter

The long axis of the ultrasound probe is placed vertical to the long axis of the adductor canal while scanning, and the catheter is placed along the short axis of the canal using an in-plane approach

DEVICEPhilip CX 50 Ultrasound Scanner

The linear (C5-12) probe of Philip CX 50 Ultrasound Scanner is used for scanning

DRUGRopivocaine

0.2% ropivacaine 10ml is given as loading dose. Following that, 0.2% ropivacaine 5ml/h is given as maintenance dose.

DRUGrescue sulfentanil given postoperatively as PICA

bolus: 2mg, lock time: 10min, 1h limitation: 8mg

Sponsors

Medical Consulting Center
CollaboratorNETWORK
Cui Xulei
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* 18-80 years * Knee-arthroscopy * Written consent * ASA I-III * BMI 19-35

Exclusion criteria

* Unable to communicate with the investigators (e.g., a language barrier or a neuropsychiatric disorder). * coagulopathy or on anticoagulant medication * Allergic reactions toward drugs used in the trial * History of substance abuse * Infection at injection site * Can not be mobilised to 5 meters of walk pre-surgery

Design outcomes

Primary

MeasureTime frameDescription
the strength of quadriceps femoriswithin 48hours after surgerystrength of quadriceps femoris measured on a Lovett muscle strength rating-scale within 48 hours after surgery

Secondary

MeasureTime frameDescription
ambulation timewithin the 7 days after surgerySAX-group vs. LAX-group
quality of recovery3days and 7days after surgeryuse the self-assessment 11item QoR scale to assess the patient's recovery quality,SAX-group vs. LAX-group
complicationswithin the 7 days after surgeryRecord complications including catheter dislodgment, puncture point infection, leakage,falling down,et al.
postoperative nausea and vomiting score0-2, 2-4, 4-8, 8-24, 24-48 hours postoperativeRating-scale 0-3 SAX-group vs. LAX-group
Pain-score (VAS), patient at rest0,2,4,8,24,48 hours postoperativePain-score measured on a Visual Analog Scale (VAS) .SAX-group vs. LAX-group
Pain-score (VAS), motion pain0,2,4,8,24,48 hours postoperativePain-score measured on a Visual Analog Scale (VAS) .SAX-group vs. LAX-group
sulfentanil consumption0,2,4,8,24,48 hours postoperativerecord the amount(ml) of sulfentanil used
the strength of quadriceps femoris0,2,4,8,24,48 hours postoperativeSAX-group vs. LAX-group

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026